Travere Therapeutics (NasdaqGM:TVTX) 2026 Conference February 11, 2026 04:00 PM ET Company ParticipantsChris Cline - CFOEric Dube - President and CEOConference Call ParticipantsVamil Divan - Biopharma AnalystVamil DivanAll right, I think we're ready to get started. So, thanks everyone for joining us for this year's Biotech Summit here at Guggenheim. I'm Vamil Divan, one of the biopharma analysts here. Next up in this room, we have the Travere Therapeutics team. Next to me, Eric Dube, the President and CEO, ...

Fourth Quarter 2025 Business Review FEBRUARY 11, 2026 1 © 2026 | AURORA PROPRIETARY Cautionary statement regarding forward-looking statements This presentation contains certain forward-looking statements within the meaning of the federal securities laws. The words "believe,ˮ "may,ˮ "will,ˮ "estimate,ˮ "continue,ˮ "anticipate,ˮ "intend,ˮ "expect,ˮ "could,ˮ "would,ˮ "project,ˮ "plan,ˮ "potential,ˮ "target,ˮ and similar expressions and variations thereof are intended to identify forward-looking statements, but ...

QuidelOrtho Fourth Quarter and Full-Year 2025 Financial Results February 11, 2026 QuidelOrtho – Proprietary & Confidential. | © 2025. All Rights Reserved. 2 Forward-Looking Statements and Non-GAAP Financial Measures Forward-Looking Statements: This presentation of QuidelOrtho Corporation ("QuidelOrtho" or the "Company") contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are any statement contained herein that is not strictly his ...

Inspire Medical Systems, Inc. February 2026 NYSE: INSP This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forward-looking statements, including, without limitation, statements regarding potential impacts to our business associated with Inspire V reimbursement, our plans to obtain a long-term solution that would support appropriate reimbursement for Inspire V, and our ex ...

Earnings Presentation Q4 and Full-Year 2025 Results | February 11, 2026 Safe Harbor A number of forward-looking statements will be made during this presentation. Forward-looking statements are any statements that are not historical facts. These forward-looking statements are based on the current expectations of Motorola Solutions, and we can give no assurance that any future results or events discussed in these statements will be achieved. Any forward-looking statements represent our views only as of today ...

Q4 2025 Earnings Presentation February 11, 2026 Copyright 2026 Porch Group, Inc. All rights reserved Disclaimers Financial Targets Porch is providing guidance and targets for future periods in this presentation, based on current market conditions, assumptions, and expectations as of the date of this presentation. Actual results may vary due to a number of factors, and there is no guarantee that we will be able to achieve these results. Please refer to the below for important disclaimers and a description of ...

February 11, 2026 Q2 02 Safe Harbor Statement 4th Quarter & Full-Year 2025 Results This presentation and the accompanying oral presentation contain forward-looking statements and information that are based on our management's beliefs and assumptions and our manacement. The satements and information cortained in this presentation that are not purel historical are corward-looking statements within the meaning of the Private Section 21A di the Seourities Act of 1933, as amerched, and Section 21E of the Securit ...

2Q FY26 Result Presentation Mr. Todd Abbott – Chief Executive Officer North America: February 11, 2026 | Australia: February 12, 2026 ` NYSE: TBN, ASX: TBN For personal use only Disclaimer The information in this presentation includes "forward -looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), which include statements on Tamboran Resources Corporation ...

Zentalis Pharmaceuticals (NasdaqGM:ZNTL) 2026 Conference February 11, 2026 03:30 PM ET Company ParticipantsIngmar Bruns - CMOJulie Eastland - President and CEOConference Call ParticipantsMichael Schmidt - Senior Biotech AnalystMichael SchmidtKicking off the next fireside chat here. My name is Michael Schmidt, Senior Biotech Analyst with Guggenheim, and I'm really happy to welcome, Julie Eastland, President and CEO of Zentalis, and she's joined by, Ingmar Bruns, Chief Medical Officer. Welcome. Thanks for joi ...

February 11, 2026 Investor Presentation Q4 FY 2025 ©2026 Fastly, Inc. Fastly Q4 2025 Earnings Investor Deck (2/11/2026) 2 Investment highlights Clear market leader with differentiated technology Unified platform centered on innovation Large and growing addressable market Internet and AI trends driving significant opportunity Mission-critical platform vital for customer operations Multiple ways to accelerate and sustain growth ©2026 Fastly, Inc. Fastly Q4 2025 Earnings Investor Deck (2/11/2026) Forward Looki ...